ASCo held “Pharma Associations
Conference 2014-Global Partnering for Open Innovation” on 18th – 19th of
November, 2014 in Grand Ballroom of Ritz-Carlton
Seoul.
The conference attracted more than 300 delegates from 100 companies and organization from
a Pharmaceutical and medical sectors.
Speakers, Panelists and Moderators included:
Woo Ick Jang, Handok Inc.│Executive Vice President and Head of R&D
Byoungjun Bae, Ministry of Health & Welfare│Director
General, Bureau of Health Industry
Robert J. Hariri, Celgen │Chairman,
Founder and CSO for Cellular Therapeutics
Yil-Seob Lee, GSK│Head
of Medical, Regulatory & Market Access
Jia-Hua Wang, Novartis│Oncology
Director Asia Pacific Region Medical Affairs
Baekmin Seong, Novartis│Head
Strategic partnership Korea/Asia Lead in BD&L
Joong-Gon Kim, Seoul National University
Jei-Wook Chae, Bioneer Inc. │Head
of Therapeutic RNA Development
Younggyu Cho, Handok Inc│Head of Bio-Research Center
Wan Namkung, Yonsei University
Kenichi Nishida, Daiichi-Sankyo│Senior Director External Science Planning, R&D Planning
Department
Frank Degner, Boehringer Ingelheim│Head Clinical Development & Medical Affairs
Young-Guen Kwon, Yonsei University
Kyeong-Cheon Jung, Dinona Inc.
Yoon-Won Kim, ImmuneMed Inc.│President & CEO
James Jun, KT&G Life Science│CEO
Yariv Hefez, Merck Serono│Vice President Business Development, Licensing & Alliance Management
Yuan-Hua Ding, Pfizer│Executive
Director & Head External R&D Innovation (ERDI)-Asia Pacific
Elena Rizova, Janssen│Vice
President, Head of External Innovation J&J Innovation Center Asia Pacific
Young-Woo Park, KRIBB│Principal
Research Scientist, Korea Research Institute of Bioscience &Biotechnology (KRIBB)
Jin-San Yoo, PharmaAbvine, Inc.│CEO, President and Founder
Soon-Jae Park, Alteogen Inc. │CEO
Seong-Choon CHOE, M.D.,
Ph.D. Deputy Head, R&D Center, Head of Seoul Research Institute at Boryung Pharm.Co.
In-Chull Kim, National Oncoventure│President
Jung Yong Kim, NOV │CEO
(National Oncovenure)
Young-Whan Park, NOV│Senior
Vice President and Head of Business Development
Joy H.J. Chung, KHIDI│Executive
Consultant
Takato Noumi, Sanofi│Director
External Science & Partnering Japan
Hiroya Muranishi, Takeda│Senior
Director Research Alliance, Pharmaceutical Research
Bong Yong Lee, Daewoong Pharmaceutical Co.Ltd.│Head of Research
Dong Hoon Jin, Ulsan University
Yong H Rho, Obetat Biopharma│President
Wheeseong Lee, KT&G Life Sciences│CTO / Head of R&D Center
Near the end of the
conference, we asked our delegates to kindly fill out an evaluation form. The
following results were produced after collating the evaluation forms: